Stanford University
Showing 6,251-6,300 of 7,810 Results
-
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics), of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe answer clinical questions using aggregate patient data at the bedside. The Informatics Consult Service (https://greenbutton.stanford.edu/) put this idea in action and led to the creation of Atropos Health. We build predictive models that allow taking mitigating actions, keeping the human in the loop.
-
Nirao Shah
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Ripal Shah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Associate Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, supplements, exercise, behavioral modifications, hypnosis), and in high performers such as physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians). Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, ethnicity-dependent variability in mental health access and treatment response, psychedelics, spirituality, minority stress, and the role of Eastern religions on mental health in the U.S. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with relationships or loss of a partner; grief or loss of a parent, sibling, child, or partner; issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation); as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, she served as Chief Resident and led community partnerships and DEI efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for programs across the country, built and then graduated from a Diversity & Health Equity track in the residency, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry.
She is board certified in Adult Psychiatry, Addiction Medicine, Obesity Medicine, and Integrative Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. She has been credentialed in TMS (transcranial magnetic stimulation), ECT (electroconvulsive therapy), hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD). She advises several companies and research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
Sajan Shah, MD, MBA
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Sajan Shah is a board-certified, fellowship-trained pain management specialist with the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine.
Dr. Shah specializes in managing acute and chronic pain. He commonly cares for people living with complex spinal conditions that have not responded to conventional treatment. He offers a range of injections to manage pain, including joint corticosteroid injections, peripheral nerve blocks, trigger point injections, and Botox injections for migraines and dystonia. He has experience with neuromodulation techniques, including spinal cord stimulation and peripheral nerve stimulation, and minimally invasive spinal procedures. He strives to provide effective pain therapies that improve the everyday function and quality of life of his patients.
Dr. Shah’s research has explored topics in anesthesiology and pain medicine. He has studied chronic pain syndromes, including how to diagnose and manage rare pain conditions. Dr. Shah has published his findings in several peer-reviewed journals and co-authored a book chapter on complex regional pain syndrome. He has presented his research at national and international meetings, including those held by the American Academy of Pain Medicine, American Society of Regional Anesthesia and Pain Medicine, and North American Neuromodulation Society. -
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, bladder, kidney, and testicular cancers. He serves as an investigator on numerous clinical trials, with a particular focus on novel immunotherapy agents. His academic interests also encompass digital health technologies and innovative healthcare delivery models. He has lectured internationally on the management of urologic cancers and currently serves on the National Cancer Center Network (NCCN) Panel for testicular cancer.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Healthcare Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD currently serves as Chief of the Medical Staff for Stanford Health Care. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine. His clinical focus is on bladder cancer, and he is well known for his expertise in robotic surgery. His academic interests center on optimizing outcomes after bladder removal surgery. He is very active in leadership development, team building, and quality improvement work and he lectures nationally and internationally on these topics. He is also certified by the International Coaching Federation as an executive coach.
Dr. Shah graduated from Harvard College, and he completed medical school and urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center and then joined the faculty there. During his time at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, and exploring the beaches of Northern California with his family and three dogs.
In his free time, Dr. Shah enjoys reading, cooking, surfing, hiking and exploring the beaches of Northern California in his Jeep Wrangler with his family and 2 dogs. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioI lead a computational oncology laboratory that develops machine learning and statistical methods for high-dimensional genomics, with particular expertise in Bayesian and uncertainty-aware modeling to integrate prior biological knowledge with large-scale datasets.
Our research centers on liquid biopsy analytics—especially cell-free DNA (cfDNA)—to noninvasively quantify genetic and epigenetic states relevant to cancer detection, monitoring, and tumor evolution. We developed EPIC-seq, a fragmentomics-based method that uses cfDNA fragmentation patterns to infer regulatory activity and gene expression programs, providing a scalable framework for epigenetic profiling from blood.
A core methodological focus of the lab is enabling reliable inference in extremely low signal-to-noise settings that are typical of cfDNA and early-stage disease. We build robust, interpretable models and benchmarking frameworks that support clinical translation, with the long-term aim of democratizing access to sensitive, minimally invasive cancer diagnostics. -
Cory Shain
Assistant Professor of Linguistics and, by courtesy, of Psychology
BioI lead the Laboratory for Computation & Language in Minds & Brains (CLiMB Lab). We try to figure out how our brains let us go so efficiently from sensation (e.g., speech, reading) to meaning, and we do this using a combination of neuroimaging, computer modeling, and behavioral experiments. See the lab website for details.
-
Mehrdad Shamloo
Professor (Research) of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe ultimate goal of the Shamloo laboratory is to rapidly advance our understanding of brain function at the molecular, cellular, circuit and behavioral levels, and to elucidate the pathological process underlying malfunction of the nervous system following injury and neurologic disorders such as stroke, Alzheimer's disease, Parkinson’s disease, and autism. We have been focusing on the noradrenergic system and approaches leading to restoration of brain adrenergic signaling in these disorders.
-
Hua Shan
Professor of Pathology
BioDr. Shan specializes in providing blood transfusion and apheresis treatment to patients with diverse medical problems. She has been practicing transfusion medicine for over thirty years. Dr. Shan served as the Medical Director of Transfusion Service at Stanford Medical Center from 2015 to 2026. Dr. Shan has also been leading research and education programs in the fields of transfusion safety, optimizing clinical blood transfusion practice and blood availability.
-
Vikram Shankar, MD
Clinical Instructor, Ophthalmology
BioDr. Shankar, MD, MPH, is a board-certified, fellowship-trained ophthalmologist at the Stanford Health Care Byers Eye Institute. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Shankar’s clinical focus is the medical and surgical care of cataracts and adult glaucoma, including premium lenses and minimally invasive glaucoma surgery (MIGS). Dr. Shankar’s research and professional interests include ophthalmic public health, biomedical devices, and digital health. He has a particular interest in the intersection of entrepreneurship, public health, and ophthalmology, aiming to find innovative solutions that will impact millions of patients.
Dr. Shankar has published research on lung cancer metastasis to the optic nerve, pharmacologic therapies in glaucoma, and surgical outcomes with a novel glaucoma device. He has also delivered presentations nationwide on topics including screening rates for diabetic retinopathy based on insurance type and socioeconomic factors, Medicaid expansion, and health disparities.
Dr. Shankar completed a combined MD/MPH at Washington University in St. Louis School of Medicine. He earned the Albert F. Koetter, MD Scholarship; Dean’s Research Fellowship; and Jonathan Mann Fellowship as a medical student. He completed his ophthalmology residency at the Wills Eye Hospital in Philadelphia, PA. He subsequently completed his fellowship in glaucoma at the Stanford Byers Eye Institute.
Dr. Shankar is the cofounder of a seed-stage ophthalmic medical device startup that aims to improve patient safety and mitigate the environmental impact of eye care worldwide.
Dr. Shankar is a member of the American Academy of Ophthalmology. -
Michael Shanks
Professor of Classics
BioProfessor at Stanford University, Michael Shanks is one of the most original and influential of contemporary archaeologists. He has been at the forefront of archaeological thought and practice since the 1980s, pioneering new ways of understanding and explaining, engaging with Graeco-Roman antiquity and European prehistory, mobilizing remains of the past all around us — instigating changes in archaeology and how we all work with remains of the past. A specialist in long-term perspectives on design and creativity, innovation and social change, he explores connections across the sciences, humanities, and arts in research collaborations and outreach through and beyond the academy, tapping more than $32m of funding over the last 25 years.
Current projects
MS is currently completing four long-running and interrelated projects.
Archaeological history — building scenarios.
Greece and Rome: a new model of antiquity. With Gary Devore. A project concerned with how one might conceive of antiquity as a kind of archaeological prehistory, retold through speculative fabulation. Against conventional narrative is offered a model of ancient lifeworlds conveyed through 45 personae and scenarios. Estimated delivery end of 2026.
Archaeological sites — encountering location.
Against place: a border archaeology. Based on archaeological itineraries in the northern borders of England/Scotland, including prehistoric and Roman field research, this project explores border crossings, trespass and transgression in questioning the character of space and place, site and region. Estimated delivery 2027.
Archaeological praxis — performance design.
Theatre/Archaeology: performing remains. With Mike Pearson. This book sums up 30 years of collaboration with performance artist Mike Pearson. In five portfolios of case studies in performance design they set out a pragmatics and methodology of deep mapping contemporary antiquity and prehistory. Estimated delivery end of 2025.
Archaeological actuality — for the future.
Archaeologies of Nature in Art: from Landscape to Climate Breakdown. With Gabriella Giannachi. This project mobilizes an archaeology of arts practices, from prehistory to contemporary art, to offer action-oriented responses to climate change in a reframing of the concept of nature. Estimated delivery autumn 2025.
The following is part of his continuing exploration of Applied Archaeology — design foresight.
Project Athena: Innovation in and through Learning. With Aisin Corporation led by Kenji Suzuki and in collaboration with Kimihiko Iwamura. Developing learning community and competencies in creative pragmatics — designing and implementing a strategy of corporate culture change. Ongoing 2025 – 2026. -
Lucy Shapiro
Virginia and D. K. Ludwig Professor, Emerita
Current Research and Scholarly InterestsA basic question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code. Our goal is to define these mechanisms using both molecular genetics and biochemistry.
-
Eric S.G. Shaqfeh
Lester Levi Carter Professor and Professor of Mechanical Engineering
Current Research and Scholarly InterestsI have over 25 years experience in theoretical and computational research related to complex fluids following my PhD in 1986. This includes work in suspension mechanics of rigid partlcles (rods), solution mechanics of polymers and most recently suspensions of vesicles, capsules and mixtures of these with rigid particles. My research group is internationally known for pioneering work in all these areas.
-
Naima G. Sharaf
Assistant Professor of Biology and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsResearch in the lab bridges biology, microbiology, and immunology to translate lipoprotein research into therapeutics
-
Paul Sharek MD, MPH
Professor of Pediatrics (Hospital Medicine) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsResearch interests centered on hospital based quality of care improvement, and in particular pediatric patient safety. Areas of recent interest include developing practical tools to more accurately identify adverse medical events and to establish national rates of these adverse events. Additional areas of interest focus on developing the processes and systems to decrease the frequency of adverse drug events and adverse medical events at Children's hospitals in North America
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. In addition to seeing patients in the intensive care unit (ICU), I focus my research and clinical practice on transplant-related pulmonary fibrosis, which includes fibrotic lung disease after lung transplant or after hematopoietic cell transplant. My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my training in engineering and bioinformatics. In the clinical setting I see patients in a Lung Graft-versus-Host-Disease (GVHD) Clinic for individuals with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a national Lung GVHD Consortium comprising Stanford, Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health. The first trial uses a home spirometry device and monitoring system to study the association of Lung GVHD with respiratory viral infections. The second trial studies the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. My goal is to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
See my website at https://www.sharifi.com/. -
Rahul P Sharma, MBBS, FRACP
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Carla Shatz
Sapp Family Provostial Professor and Professor of Biology and of Neurobiology
Current Research and Scholarly InterestsThe goal of research in the Shatz Laboratory is to discover how brain circuits are tuned up by experience during critical periods of development both before and after birth by elucidating cellular and molecular mechanisms that transform early fetal and neonatal brain circuits into mature connections. To discover mechanistic underpinnings of circuit tuning, the lab has conducted functional screens for genes regulated by neural activity and studied their function for vision, learning and memory.
-
Rich Shavelson
Margaret Jacks Professor of Education, Emeritus
Current Research and Scholarly InterestsAssessment of learning in higher education (including the Collegiate Learning Assessment); accountability in higher education; higher education policy.
-
Gary M. Shaw
Rosemarie Hess Professor and Professor (Research), by courtesy, of Epidemiology and Population Health and of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsPrimary research interests include 1) epidemiology of birth defects, 2) gene-environment approaches to perinatal outcomes, and 3) nutrition and reproductive outcomes.
-
Jonathan Shaw
Clinical Professor (By courtesy), Obstetrics & Gynecology
Current Research and Scholarly InterestsPrimary care, psycho-social determinants of health & care, maternal-child health
-
Kate Shaw, MD MS
Associate Professor of Obstetrics and Gynecology (Gynecology & Gynecologic Specialties/Complex Family Planning)
Current Research and Scholarly InterestsMy research interests include expanding access to and and improving patient experience with contraception and abortion care both domestically and globally. I am also interested in medical education and resilience among physicians and trainees.
-
Richard J. Shaw, M.D.
Professor of Psychiatry and Behavioral Sciences (Child & Adolescent Psychiatry), Emeritus
Current Research and Scholarly InterestsPsychological issues in medically ill children.
Medical posttraumatic stress disorder.
Treatment adherence.
Transplant psychiatry.
Pediatric oncology.
Forensic psychiatry. -
Xinshu She
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMy current interests include global mental health promotion in underserved pediatric populations, including refugee health in US-Mexico borders, minority mental health in the US, and parental mental health in low-middle-income countries. I am also interested in physician wellness and Diversity and Inclusion.
-
Kevin Shea
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics
BioKevin G. Shea, MD is at Stanford University. He grew up in Montana and California, graduated from the University of Notre Dame, UCLA School of Medicine, and completed his orthopaedic residency at the University of Utah. His advanced training includes pediatric orthopaedics at Rady Children’s Hospital in San Diego, AO Fellowship in Bern Switzerland with Dr. Ganz (Hip), Dr. Diego Fernandez (Trauma), and Dr. Hans Staubli (sports), Ilizarov Training in Lecco, Italy. He has done the AOSSM South American Traveling Sports Medicine Fellowship, and education in Russia and former Soviet Bloc countries. Most of his early career was in Boise, Idaho. Dr. Shea is a founding member of the PRISM Society (Pediatric Research in Sports Medicine) and the ROCK (Research in Osteochondritis Dissecans of the Knee) Multi-center Study Group, and the SCORE (Sports Cohort Outcomes Research ) Multi-Center Registry for pediatric sports. He has authored more than 300 scientific papers and chapters. His clinic research interests include cartilage and ligament disorders, using pediatric cadaveric tissue and surgical 3D simulations to develop surgeries and improve outcomes for procedures that avoid damage to growth plates. He has years of experience with performance, quality improvement, value, and he worked extensively with the AAOS Quality/Clinical Practice Guideline Committees. He is one of the POSNA members to launch the POSNA Safe Surgery Program. He is a national quality leader in health care with interests in patient safety, risk reduction, and improving value in health care with clinician integration into supply chain. He is an avid cyclist, trail runner, hiker, and spends as much time outside as possible, with his partner Lonnie and their children Beck and Cooper.
-
Alicia Myles Sheares
Assistant Professor of Management Science and Engineering and, by courtesy, of Sociology
BioProfessor Alicia Myles Sheares is an Assistant Professor in the Management Science and Engineering department at Stanford University. Her research sits at the intersection of race and organizations with a specific focus on how underrepresented professionals of color fare in the United States. Currently, she’s working on two major projects. The first explores the experiences of Black tech entrepreneurs in Silicon Valley and Atlanta, while the second explores individual and company-level factors that are associated with success among Black and Latine startups in the U.S. Her research has been published in Social Forces, the Sociology of Race and Ethnicity, Big Data and Society, and the International Migration Review. Professor Sheares was a University of California President’s Postdoctoral Fellow at UCLA. She received her Ph.D. in sociology from UC Berkeley, her M.Sc. in Migration Studies from the University of Oxford, and her B.A. from Spelman College.
Email: asheares@stanford.edu -
Clifford Sheckter, MD, MS, FACS, FABA
Associate Professor of Surgery (Plastic and Reconstructive Surgery)
BioDr. Cliff Sheckter is a California native, growing up in the rural Eastern Sierra. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC (Keck) for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He fell in love with burn care while at USC/LA General Medical Center and completed surgical training at Stanford. While in residency, he pursued a fellowship/postdoc in Health Systems Design at Stanford’s Clinical Excellence Research Center (CERC). He earned an MS in Health Policy from Stanford, focusing on health economics. He received additional training in Surgical Critical Care and Burn Surgery at the University of Washington.
Dr. Sheckter is a health services and health policy researcher. His work focuses on burn prevention and health economics in surgical care. He has authored over 155 articles and numerous book chapters. His research has been published in JAMA, JAMA Network Open, JAMA Surgery, Annals of Surgery, Journal of Plastic & Reconstructive Surgery, Burns, and Journal of Burn Care & Research. His work has been featured in USA Today and the New York Times. He was the recipient of a career development award from the NIH and has funding from the Plastic Surgery Foundation. Dr. Sheckter was awarded the American Burn Association (ABA) Traveling Fellow for 2023 and has won top abstract at the ABA Annual Meeting multiple times. He is an active member of the ABA and Chairs the Burn Prevention Committee.
Dr. Sheckter is one of a few surgeons double-board certified in Surgical Critical Care and Plastic & Reconstructive Surgery. He practices critical care medicine as an intensivist in the Stanford Surgical ICU. He is the Director of the Burn Center at Santa Clara Valley Medical Center which is the only burn/trauma center for the San Francisco Bay Area. He performs scar reconstruction using surgical and laser techniques.
